Md. Code, Health-Gen. § 19-308.11

Current with changes from the 2024 Legislative Session
Section 19-308.11 - [Effective 1/1/2025] Medication for opioid use disorder
(a) In this section , "medication for opioid use disorder";
(1) Means a drug approved by the U.S. Food and Drug Administration for the treatment of opioid use disorder; and
(2) Does not include a drug administered to mitigate opioid-related overdose symptoms.
(b) Each hospital shall establish and maintain, as part of its emergency services, protocols and capacity to:
(1) Provide to a patient before discharging the patient appropriate, evidence-based interventions that reduce the risk of subsequent harm and fatality following an opioid-related overdose or a visit for an opioid-related emergency medical condition;
(2) Possess at least one formulation of each U.S. Food and Drug Administration-approved full opioid agonist and partial opioid agonist used for the treatment of opioid use disorder; and
(3) Treat a patient who presents in a hospital emergency department for care and treatment of an opioid-related overdose or opioid-related emergency medical condition with a medication for opioid use disorder if the treatment:
(i) Occurs as recommended by the treating health care practitioner; and
(ii) Is voluntarily agreed to by the patient.
(c) A protocol established by a hospital under this section shall include:
(1)

Any requirement by the Department regarding prescribing opioid agonist treatment;

(2) Uniform practices for screening and diagnosing individuals who present with an opioid-related overdose or opioid-related emergency medical condition for an opioid use disorder based on the criteria in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders;
(3) Uniform practices for offering and administering opioid agonist medication to treat an opioid-related overdose or opioid use disorder; and
(4) Uniform practices to identify community-based treatment services that are appropriate for:
(i) Treating opioid use disorders; and
(ii) Assisting patients to voluntarily access ongoing community-based treatment at discharge.
(d) Before discharging a patient who is diagnosed with an opioid use disorder or administered or prescribed medication for opioid use disorder, a hospital shall :
(1) Make a referral of the patient to an appropriate provider or facility for a timely appointment, when possible, to voluntarily continue treatment in the community; and
(2) Work with peer support professionals, as available, or other resources to assist the patient in accessing the identified treatment services.

Md. Code, HG § 19-308.11

Added by 2024 Md. Laws, Ch. 886,Sec. 1, eff. 1/1/2025.
Added by 2024 Md. Laws, Ch. 885,Sec. 1, eff. 1/1/2025.